| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050701040 |
| P356 | DOI | 10.1007/S00109-012-0892-1 |
| P698 | PubMed publication ID | 22552382 |
| P5875 | ResearchGate publication ID | 224888151 |
| P50 | author | Martin A. Nowak | Q87451 |
| Alison L Hill | Q56743467 | ||
| P2093 | author name string | Daniel I S Rosenbloom | |
| P2860 | cites work | High GUD incidence in the early 20 century created a particularly permissive time window for the origin and initial spread of epidemic HIV strains | Q21142612 |
| Dating the age of the SIV lineages that gave rise to HIV-1 and HIV-2 | Q21563512 | ||
| Identifying HIV-1 dual infections | Q22241756 | ||
| Chimpanzee reservoirs of pandemic and nonpandemic HIV-1 | Q22242279 | ||
| Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS | Q22242658 | ||
| HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse | Q22242967 | ||
| The causes and consequences of HIV evolution | Q22251040 | ||
| Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy | Q22251085 | ||
| Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960 | Q22251093 | ||
| Simian immunodeficiency virus infection in free-ranging sooty mangabeys (Cercocebus atys atys) from the Taï Forest, Côte d'Ivoire: implications for the origin of epidemic human immunodeficiency virus type 2. | Q24533334 | ||
| Bacterial persistence: a model of survival in changing environments | Q24544968 | ||
| Viral Evolution and Escape during Acute HIV‐1 Infection | Q24600713 | ||
| Phenotypic mixing and hiding may contribute to memory in viral quasispecies | Q24805745 | ||
| An HIV feedback resistor: auto-regulatory circuit deactivator and noise buffer | Q27334904 | ||
| DNA deamination mediates innate immunity to retroviral infection | Q28179534 | ||
| Hypermutation of HIV-1 DNA in the Absence of the Vif Protein | Q28204475 | ||
| An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome | Q28208180 | ||
| The challenge of viral reservoirs in HIV-1 infection | Q28216956 | ||
| HIV surveillance--United States, 1981-2008 | Q28239415 | ||
| Antigenic Diversity Thresholds and the Development of AIDS | Q28251063 | ||
| Naturally acquired simian retrovirus infections in central African hunters | Q28252669 | ||
| Epidemiology and genetics in the coevolution of parasites and hosts | Q28261345 | ||
| Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition | Q28282470 | ||
| Coinfection and the evolution of parasite virulence | Q28290024 | ||
| Island biogeography reveals the deep history of SIV | Q28293475 | ||
| HIV pathogenesis: 25 years of progress and persistent challenges | Q28304671 | ||
| Transmission dynamics of HIV infection | Q28305266 | ||
| The role of compensatory mutations in the emergence of drug resistance | Q28469058 | ||
| Recombination rate and selection strength in HIV intra-patient evolution | Q28472689 | ||
| Accelerated immunodeficiency by anti-CCR5 treatment in HIV infection | Q28475890 | ||
| Assessing predicted HIV-1 replicative capacity in a clinical setting | Q28477801 | ||
| Purifying selection can obscure the ancient age of viral lineages | Q28740712 | ||
| Discovery and analysis of the first endogenous lentivirus | Q28762926 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Antibody neutralization and escape by HIV-1 | Q29547345 | ||
| Is a new and general theory of molecular systematics emerging? | Q29614319 | ||
| Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 | ||
| Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Q29619510 | ||
| Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase | Q29619994 | ||
| HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion | Q30233544 | ||
| Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. | Q30352625 | ||
| HIV/AIDS epidemiology, pathogenesis, prevention, and treatment | Q30356074 | ||
| Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity | Q33220546 | ||
| Understanding the slow depletion of memory CD4+ T cells in HIV infection | Q33285394 | ||
| Mathematical biology of HIV infections: antigenic variation and diversity threshold | Q33344856 | ||
| Dynamics of immune escape during HIV/SIV infection | Q33352680 | ||
| Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness | Q37120860 | ||
| HLA-associated viral mutations are common in human immunodeficiency virus type 1 elite controllers | Q37127920 | ||
| Has HIV evolved to induce immune pathogenesis? | Q37182122 | ||
| Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy | Q37200979 | ||
| Evolutionary history and phylogeography of human viruses | Q37266521 | ||
| Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs | Q37345610 | ||
| Dynamics of HIV-1 recombination in its natural target cells | Q37356815 | ||
| The latent reservoir for HIV-1 in resting CD4+ T cells: a barrier to cure | Q37446807 | ||
| Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment | Q37492836 | ||
| Stochastic gene expression as a molecular switch for viral latency | Q37549111 | ||
| A novel method for determining the inhibitory potential of anti-HIV drugs | Q37616810 | ||
| Compensation of fitness costs and reversibility of antibiotic resistance mutations | Q37696851 | ||
| Call of the wild: antibiotic resistance genes in natural environments | Q37700168 | ||
| Pathogenic Mechanisms of HIV Disease | Q37804860 | ||
| Population biological principles of drug-resistance evolution in infectious diseases | Q37849394 | ||
| Evolutionary pathways of transmitted drug-resistant HIV-1. | Q37866540 | ||
| Effect of multiple infection of cells on the evolutionary dynamics of HIV in vivo: implications for host adaptation mechanisms | Q37902370 | ||
| HIV-1 mutational pathways under multidrug therapy | Q38264403 | ||
| The effect of transmitted HIV-1 drug resistance on pre-therapy viral load | Q38444075 | ||
| A strong case for viral genetic factors in HIV virulence | Q38615326 | ||
| Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco | Q39909667 | ||
| Life-history tactics: a review of the ideas | Q40549510 | ||
| Follicular dendritic cells and the persistence of HIV infectivity: the role of antibodies and Fcgamma receptors | Q40748993 | ||
| Theory of lethal mutagenesis for viruses | Q41979840 | ||
| Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus | Q42737606 | ||
| Demonstration of sustained drug-resistant human immunodeficiency virus type 1 lineages circulating among treatment-naïve individuals | Q43173413 | ||
| The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors | Q43576040 | ||
| Dr. William H. Stewart: mistaken or maligned? | Q43749862 | ||
| Recombination: Multiply infected spleen cells in HIV patients | Q43923409 | ||
| Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses | Q44307172 | ||
| The frequency of resistant mutant virus before antiviral therapy | Q44753747 | ||
| AIDS/HIV. Converging on an HIV vaccine | Q45008312 | ||
| Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study | Q45057839 | ||
| Virus strains of identical phenotype but different genotype | Q45691489 | ||
| Virus dynamics: the effect of target cell limitation and immune responses on virus evolution | Q45755458 | ||
| Antigenic oscillations and shifting immunodominance in HIV-1 infections. | Q45869472 | ||
| Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. | Q45994251 | ||
| The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models | Q46193879 | ||
| HIV evolution: CTL escape mutation and reversion after transmission | Q47211742 | ||
| Methods for optimizing antiviral combination therapies | Q47767090 | ||
| Imperfect vaccines and the evolution of pathogen virulence | Q47896350 | ||
| Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia | Q48023288 | ||
| Comparing two Bayesian methods for gene tree/species tree reconstruction: simulations with incomplete lineage sorting and horizontal gene transfer. | Q51597108 | ||
| HIV coreceptor usage and drug treatment. | Q52010514 | ||
| Pre-existence and emergence of drug resistance in HIV-1 infection. | Q52264204 | ||
| Reduction of HIV concentration during acute infection: independence from a specific immune response. | Q52312556 | ||
| A model for AIDS pathogenesis. | Q52368729 | ||
| Superinfection and the evolution of parasite virulence. | Q52382956 | ||
| On the greatly exaggerated reports of the death of infectious diseases. | Q53130472 | ||
| Recombination in HIV and the evolution of drug resistance: for better or for worse? | Q53905007 | ||
| No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection. | Q55398991 | ||
| What is a quasispecies? | Q56060179 | ||
| The Evolution of Life History Traits: A Critique of the Theory and a Review of the Data | Q56535048 | ||
| Infectious Diseases: Considerations for the 21st Century | Q56551084 | ||
| Mutating away from your enemies: The evolution of mutation rate in a host–parasite system | Q63379835 | ||
| From HIV infection to AIDS: a dynamically induced percolation transition? | Q78417132 | ||
| Stable coreceptor usage of HIV in patients with ongoing treatment failure on HAART | Q79148720 | ||
| Is HIV-1 evolving to a less virulent form in humans? | Q79488013 | ||
| Cornering HIV: taking advantage of interactions between selective pressures | Q79726654 | ||
| Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903 | Q80152299 | ||
| The role of mutation accumulation in HIV progression | Q81049427 | ||
| The study of elite controllers: a pure academic exercise or a potential pathway to an HIV-1 vaccine? | Q83601568 | ||
| Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule | Q35091012 | ||
| The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection | Q35213775 | ||
| Linkage disequilibrium test implies a large effective population number for HIV in vivo | Q35631448 | ||
| Epidemiology of drug resistance: implications for a post-antimicrobial era | Q35748958 | ||
| HIV and SIV CTL escape: implications for vaccine design | Q35852284 | ||
| Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know | Q35852348 | ||
| Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form | Q35947721 | ||
| Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population | Q36025234 | ||
| The HIV coreceptor switch: a population dynamical perspective | Q36152173 | ||
| Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. | Q36369965 | ||
| Antiretroviral dynamics determines HIV evolution and predicts therapy outcome | Q36374300 | ||
| Stochastic or deterministic: what is the effective population size of HIV-1? | Q36627391 | ||
| Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. | Q36673315 | ||
| Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy | Q36950611 | ||
| Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques | Q37000791 | ||
| HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1. | Q37033250 | ||
| The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements | Q37096085 | ||
| The evolutionary selective advantage of HIV-1 escape variants and the contribution of escape to the HLA-associated risk of AIDS progression | Q33378477 | ||
| Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag. | Q33385995 | ||
| Dynamic correlation between intrahost HIV-1 quasispecies evolution and disease progression | Q33392723 | ||
| HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins | Q33494829 | ||
| Quorum sensing and biofilm formation in Streptococcal infections | Q33630399 | ||
| Host genetics and HIV-1: the final phase? | Q33728658 | ||
| Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection | Q33825654 | ||
| The role of recombination for the coevolutionary dynamics of HIV and the immune response | Q33833611 | ||
| Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment | Q33847673 | ||
| HIV dynamics with multiple infections of target cells | Q33852032 | ||
| A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment. | Q33905201 | ||
| HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis | Q33982161 | ||
| Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission | Q34029430 | ||
| Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype | Q34032267 | ||
| Transmission selects for HIV-1 strains of intermediate virulence: a modelling approach | Q34055207 | ||
| Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution | Q34092644 | ||
| Ribavirin's antiviral mechanism of action: lethal mutagenesis? | Q34119894 | ||
| Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication | Q34120857 | ||
| Error catastrophe and antiviral strategy | Q34153584 | ||
| Innate immune activation in primary HIV-1 infection | Q34155538 | ||
| Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters | Q34178349 | ||
| Impact of MHC class I diversity on immune control of immunodeficiency virus replication | Q34235198 | ||
| CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication | Q34390292 | ||
| Efavirenz concentrations in CSF exceed IC50 for wild-type HIV | Q34481352 | ||
| Viral persistence: HIV's strategies of immune system evasion | Q34511611 | ||
| Mechanisms of HIV-associated lymphocyte apoptosis: 2010 | Q34545417 | ||
| Origins of HIV and the evolution of resistance to AIDS. | Q34551881 | ||
| Adaptation of HIV-1 to human leukocyte antigen class I | Q34604811 | ||
| HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment | Q34644242 | ||
| Challenges in the development of an HIV-1 vaccine | Q34657290 | ||
| Estimate of effective recombination rate and average selection coefficient for HIV in chronic infection | Q34804767 | ||
| A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo | Q34858885 | ||
| Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance | Q34937254 | ||
| P433 | issue | 5 | |
| P921 | main subject | evolutionary dynamics | Q5418700 |
| P304 | page(s) | 543-561 | |
| P577 | publication date | 2012-05-03 | |
| P1433 | published in | Journal of Molecular Medicine | Q6295593 |
| P1476 | title | Evolutionary dynamics of HIV at multiple spatial and temporal scales | |
| P478 | volume | 90 |
| Q36374300 | Antiretroviral dynamics determines HIV evolution and predicts therapy outcome |
| Q34819651 | Evidence for a continuous drift of the HIV-1 species towards higher resistance to neutralizing antibodies over the course of the epidemic |
| Q39030938 | Evolutionary scalpels for dissecting tumor ecosystems |
| Q33819189 | Genetic variation and HIV-associated neurologic disease. |
| Q47548221 | HIV evolution and diversity in ART-treated patients |
| Q92237212 | MAT2B expression correlates with poor prognosis in triple-negative breast cancer |
| Q36246775 | Persistence versus reversion of 3TC resistance in HIV-1 determine the rate of emergence of NVP resistance |
| Q42208022 | Reliable reconstruction of HIV-1 whole genome haplotypes reveals clonal interference and genetic hitchhiking among immune escape variants. |
| Q36432758 | Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein |
| Q84034063 | The evolution of evolutionary molecular medicine: genomics are transforming evolutionary biology into a science with new importance for modern medicine |
| Q37051423 | Twins, quadruplexes, and more: functional aspects of native and engineered RNA self-assembly in vivo |
Search more.